| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $958K | -87.6% |
| Cost of Revenue | $880K | -79.0% |
| Gross Profit | -$18K | -109.6% |
| R&D Expense | $7.3M | -46.4% |
| SG&A Expense | $21.9M | -2.0% |
| Operating Income | -$18.0M | +75.7% |
| Pre-tax Income | -$18.6M | +74.6% |
| Income Tax | -$9.3M | +0.0% |
| Net Income | -$72.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | -43.8% |
| Accounts Receivable | $2.0M | +40.0% |
| Current Assets | $25.5M | -34.8% |
| Total Assets | $100.1M | -37.3% |
| Current Liabilities | $12.1M | -14.3% |
| Total Liabilities | $60.5M | -35.9% |
| Stockholders' Equity | $34.3M | -47.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.6M | -26.8% |
| Capital Expenditures | $4.3M | +93.1% |
| Investing Cash Flow | -$4.3M | +68.9% |
| Financing Cash Flow | $35.8M | -54.3% |
| Free Cash Flow | -$49.9M | -30.7% |
| -13.7% |
| EPS (Basic) | -$0.66 | +8.3% |